author

 
 

Meta

Lisa Jarvis
Japan Times
COMMENTARY / World
Nov 16, 2022
New weight-loss drugs work, but who's paying?
Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren't yet on board.
Japan Times
COMMENTARY
Oct 24, 2022
New COVID-19 variants have arrived. How worried should you be?
Fearmongering headlines on the new COVID-19 variants are misleading and counter the message on the effectiveness of vaccines.
Japan Times
COMMENTARY / World
Oct 12, 2022
Don’t cancel your colonoscopy just yet
Data from a large trial on colonoscopies appears to cast doubt over the benefits of the colon cancer screen. But it's a lot more complicated.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
COMMENTARY / World
Sep 1, 2022
To fight monkeypox and other viruses, look harder in the sewers
Health authorities rely on a patchwork system for testing wastewater, often missing important information about virus outbreaks such as monkeypox.
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
COMMENTARY / World
Jun 5, 2022
Omicron is turning out to be a weak vaccine
Unvaccinated people who got COVID-19 last winter have little protection from reinfection, and even vaccinated people might be vulnerable after only a few months.
Japan Times
COMMENTARY / World
May 25, 2022
Monkeypox isn’t looking like a COVID-sized threat
It's still early, but contact-tracing efforts and analysis of the virus's genome offer hope that this outbreak can be contained.
Japan Times
COMMENTARY / World
Apr 8, 2022
Confronting AI’s potential to create new chemical weapons
Although the immediate danger seems minimal, efforts are needed to safeguard machine-learning models used in chemical and drug discovery.
Japan Times
COMMENTARY / World
Mar 9, 2022
Crispr might actually live up to its immense hype
The Nobel prize-winning technology is moving from a concept to the clinic at a breathtaking pace.

Longform

Yasuyuki Yoshida stirs a brew in a fermentation tank at his brewery in Hakusan.
The quake that shook Noto's sake brewing tradition